Summary
42 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $4.99B against $3.95B.
- The share price is below the Bulios Fair Price.
- It bought back its own shares for $1.00B in the last fiscal year, 9.0% of its market value.
- Revenue grew by 12% a year over the last 3 years.
What to watch
- The company made a loss over the last 12 months.
- Operating profit does not even cover the interest on its debt.
- Earnings per share fell by 13% a year over the last 3 years.
- It missed profit estimates 4 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 19% a year over 5 years. Over the last 3 years it grew by 12% a year. For the next fiscal year analysts expect revenue to fall by 2.1%. Earnings per share fell by 13% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $7.00M.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 14.6 years of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 17
- Hold 16
- Sell 6
Today's price within the analysts' price targets
The average target of $205.45 is 0.9% below today's price. 44% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Medicaid Solutions Segment 75%
- Medicare 14%
- Marketplace 10%
- Other Segments 0.4%
By region
The company reports no revenue by region.
Medicaid Solutions Segment brings in 75% of revenue. Other Segments grew fastest, by 86% a year.
Segments in detail